Monday, December 23, 2024
Facebook Linkedin Twitter
HomeTagsPhase I Clinical Trial

Phase I Clinical Trial

Biotechnology

Ascletis Announces First Patient Dosed in the U.S. Phase I Clinical Trial of Oral PD-L1

PR Newswire -
Ascletis Pharma Inc. announces the completion of first patient dosing in the U.S. Phase I clinical trial of ASC61, an oral PD-L1 small molecule...
Biotechnology

Zhimeng Biopharma Announces Dosing of First Subject of Its Novel Antiepileptic Drug Candidate CB03 in First-in-Human Phase I Clinical Trial

PR Newswire -
Shanghai Zhimeng Biopharma, Inc. ("Zhimeng"), announced dosing of the first participant in the US Phase I study in healthy subjects of its innovative small-molecule...
0FansLike
3,912FollowersFollow
0SubscribersSubscribe
spot_img

Hot Topics

Load more
ReadMagazine © | All rights reserved |Contact Us | Privacy Policy| Become A Guest Writer | Advertise with Us